Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Am J Chin Med ; 45(6): 1147-1156, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28830207

RESUMEN

The first record of ginseng use dates back over two millennia, and ginseng is now popular in more than 35 countries. Ginsenosides are the pharmacological constituents responsible for the beneficial effects of ginseng. There is increasing evidence that ginseng and its bioactive ingredients are involved in the regulation of nuclear receptors, molecules that act in response to the specific binding of hormones, which link to a diverse array of signaling pathways, such as the ERK and PI3K/Akt pathways. Knowledge of the mechanism of how ginseng mediates these complexes is essential for the development of multi-target phytomedicine as possible therapy for different diseases. Here, we discuss the literature on the effects of ginseng and its constituents on estrogen, glucocorticoid, peroxisome proliferator-activated, and androgen nuclear hormone receptors, as well as how ginseng and its constituents exert their biological function in the treatment of cancer, obesity, and cardiovascular and neurological disorders. The accumulated results definitely show that the nuclear receptors are cellular targets of ginsenosides, but more rigorous data are required to establish and provide a scientific basis to confirm the suggested efficacy of ginseng or products with ginsenosides.


Asunto(s)
Ginsenósidos/farmacología , Ginsenósidos/uso terapéutico , Panax/química , Fitoterapia , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Receptores Citoplasmáticos y Nucleares/efectos de los fármacos , Animales , Enfermedades Cardiovasculares/tratamiento farmacológico , Femenino , Ginsenósidos/aislamiento & purificación , Humanos , Sistema de Señalización de MAP Quinasas , Masculino , Neoplasias/tratamiento farmacológico , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Obesidad/tratamiento farmacológico , Receptores Activados del Proliferador del Peroxisoma/efectos de los fármacos , Receptores Activados del Proliferador del Peroxisoma/fisiología , Extractos Vegetales/aislamiento & purificación , Receptores Androgénicos/efectos de los fármacos , Receptores Androgénicos/fisiología , Receptores Citoplasmáticos y Nucleares/fisiología , Receptores de Estrógenos/efectos de los fármacos , Receptores de Estrógenos/fisiología , Receptores de Glucocorticoides/efectos de los fármacos , Receptores de Glucocorticoides/fisiología
2.
Environ Res ; 158: 490-498, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28709031

RESUMEN

Bisphenol A (BPA) is a well-known endocrine-disrupting chemical, and it is one of the highest volume chemicals produced worldwide. Even though several in vivo and in vitro studies showed positive associations of BPA exposure with pro-inflammatory cytokines such as tumor necrosis factor-α and interleukin (IL)-6, the mechanism by which BPA induces inflammation is unclear. We investigated the mechanism by which BPA induces inflammation (expression of inflammation-related genes, changes in oxidative stress, and cell proliferation and migration) and evaluated the effect of BPA exposure on inflammation-related markers in epidemiologic studies using repeat urine and serum samples from elderly subjects. BPA induced COX-2 expression via nuclear translocation of NF-κB and activation of mitogen-activated protein kinase (MAPK) by phosphorylation of ERK1/2 and enhanced the migration of lung cancer A549 and breast cancer MDAMB-231 cells. In two epidemiologic studies, we detected associations of BPA with six inflammation-related markers (WBC, CRP, IL-10, ALT, AST, and γ-GTP levels). Our findings probably suggest that BPA exposure induces inflammation and exacerbates tumorigenesis.


Asunto(s)
Compuestos de Bencidrilo/toxicidad , Ciclooxigenasa 2/genética , Inflamación/metabolismo , Fenoles/toxicidad , Transducción de Señal , Anciano , Anciano de 80 o más Años , Biomarcadores/metabolismo , Biomarcadores/orina , Ciclooxigenasa 2/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteínas Quinasas Activadas por Mitógenos/fisiología , República de Corea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA